NextGen Healthcare Crecimiento futuro
Future controles de criterios 3/6
Se prevé un crecimiento anual de los beneficios y los ingresos de NextGen Healthcare de 41.8% y 6.7% respectivamente, mientras que el BPA crecerá en un 42.6% al año.
Información clave
41.8%
Tasa de crecimiento de los beneficios
42.6%
Tasa de crecimiento del BPA
| Crecimiento de los beneficios de Healthcare Services | 27.5% |
| Tasa de crecimiento de los ingresos | 6.7% |
| Rentabilidad financiera futura | n/a |
| Cobertura de analistas | Good |
| Última actualización | 25 Oct 2023 |
Actualizaciones recientes sobre el crecimiento futuro
Recent updates
Is There An Opportunity With NextGen Healthcare, Inc.'s (NASDAQ:NXGN) 49% Undervaluation?
Aug 24
NextGen Healthcare, Inc. Just Recorded A 16% EPS Beat: Here's What Analysts Are Forecasting Next
Jul 27Investors Will Want NextGen Healthcare's (NASDAQ:NXGN) Growth In ROCE To Persist
Jul 13We Think NextGen Healthcare (NASDAQ:NXGN) Can Manage Its Debt With Ease
Jun 08Calculating The Fair Value Of NextGen Healthcare, Inc. (NASDAQ:NXGN)
May 19What Does NextGen Healthcare, Inc.'s (NASDAQ:NXGN) Share Price Indicate?
Mar 14We Think NextGen Healthcare (NASDAQ:NXGN) Can Manage Its Debt With Ease
Feb 27Is NextGen Healthcare, Inc. (NASDAQ:NXGN) Expensive For A Reason? A Look At Its Intrinsic Value
Dec 08These Return Metrics Don't Make NextGen Healthcare (NASDAQ:NXGN) Look Too Strong
Oct 27At US$17.85, Is It Time To Put NextGen Healthcare, Inc. (NASDAQ:NXGN) On Your Watch List?
Sep 30NextGen Enterprise solution to be used by NY-based health center
Sep 28NextGen Healthcare, Inc.'s (NASDAQ:NXGN) Intrinsic Value Is Potentially 75% Above Its Share Price
Sep 07NextGen Healthcare (NASDAQ:NXGN) Is Finding It Tricky To Allocate Its Capital
Jul 29NextGen Healthcare Non-GAAP EPS of $0.16 in-line, revenue of $153.3M in-line, 2023 revenue outlook below estimates
Jul 26Is It Too Late To Consider Buying NextGen Healthcare, Inc. (NASDAQ:NXGN)?
May 17NextGen At A Crossroads
Oct 13Is There An Opportunity With NextGen Healthcare, Inc.'s (NASDAQ:NXGN) 44% Undervaluation?
Jun 29NextGen Healthcare shares fall despite Q4 earnings beat, FY forecast
May 27The Returns On Capital At NextGen Healthcare (NASDAQ:NXGN) Don't Inspire Confidence
May 23Previsiones de crecimiento de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Flujo de caja libre | Flujo de caja operativo | Núm. de analistas medio |
|---|---|---|---|---|---|
| 3/31/2026 | 824 | 85 | 85 | 131 | 3 |
| 3/31/2025 | 770 | 62 | 73 | 101 | 8 |
| 3/31/2024 | 719 | 39 | 12 | 63 | 8 |
| 9/30/2023 | 695 | -6 | -43 | -8 | N/A |
| 6/30/2023 | 678 | 2 | 4 | 40 | N/A |
| 3/31/2023 | 653 | -3 | 6 | 44 | N/A |
| 12/31/2022 | 626 | 23 | 16 | 53 | N/A |
| 9/30/2022 | 614 | 20 | 32 | 67 | N/A |
| 6/30/2022 | 604 | 0 | 18 | 49 | N/A |
| 3/31/2022 | 596 | 2 | 25 | 54 | N/A |
| 12/31/2021 | 589 | 1 | 31 | 59 | N/A |
| 9/30/2021 | 581 | -4 | 42 | 71 | N/A |
| 6/30/2021 | 572 | 13 | 53 | 81 | N/A |
| 3/31/2021 | 557 | 10 | 70 | 99 | N/A |
| 12/31/2020 | 549 | 6 | 72 | 97 | N/A |
| 9/30/2020 | 545 | 10 | 68 | 93 | N/A |
| 6/30/2020 | 539 | 5 | 62 | 86 | N/A |
| 3/31/2020 | 540 | 7 | 59 | 86 | N/A |
| 12/31/2019 | 539 | 16 | 53 | 82 | N/A |
| 9/30/2019 | 532 | 16 | 49 | 76 | N/A |
| 6/30/2019 | 528 | 23 | 37 | 64 | N/A |
| 3/31/2019 | 529 | 24 | 25 | 50 | N/A |
| 12/31/2018 | 530 | 10 | 26 | 52 | N/A |
| 9/30/2018 | 531 | 6 | 24 | 51 | N/A |
| 6/30/2018 | 533 | 1 | 35 | 63 | N/A |
| 3/31/2018 | 531 | 2 | 45 | 74 | N/A |
| 12/31/2017 | 528 | 18 | 57 | 84 | N/A |
| 9/30/2017 | 524 | 27 | 67 | 92 | N/A |
| 6/30/2017 | 518 | 23 | N/A | 111 | N/A |
| 3/31/2017 | 510 | 18 | N/A | 110 | N/A |
| 12/31/2016 | 505 | -2 | N/A | 95 | N/A |
| 9/30/2016 | 494 | -6 | N/A | 83 | N/A |
| 6/30/2016 | 493 | -1 | N/A | 50 | N/A |
| 3/31/2016 | 492 | 6 | N/A | 41 | N/A |
| 12/31/2015 | 493 | 33 | N/A | 51 | N/A |
| 9/30/2015 | 499 | 32 | N/A | 54 | N/A |
| 6/30/2015 | 494 | 29 | N/A | 68 | N/A |
| 3/31/2015 | 490 | 27 | N/A | 83 | N/A |
| 12/31/2014 | 477 | 22 | N/A | 91 | N/A |
| 9/30/2014 | 462 | 3 | N/A | 103 | N/A |
| 6/30/2014 | 453 | 8 | N/A | 91 | N/A |
| 3/31/2014 | 445 | 16 | N/A | 104 | N/A |
| 12/31/2013 | 441 | 6 | N/A | 95 | N/A |
| 9/30/2013 | 446 | 35 | N/A | 82 | N/A |
| 6/30/2013 | 451 | 40 | N/A | 80 | N/A |
| 3/31/2013 | 460 | 43 | N/A | 68 | N/A |
| 12/31/2012 | 458 | 62 | N/A | 61 | N/A |
Previsiones de crecimiento futuro de los analistas
Ingresos vs. Tasa de ahorro: Se prevé que NXGN sea rentable en los próximos 3 años, lo que se considera un crecimiento más rápido que la tasa de ahorro (2.2%).
Beneficios vs. Mercado: Se prevé que NXGN sea rentable en los próximos 3 años, lo que se considera un crecimiento del mercado superior a la media.
Beneficios de alto crecimiento: Se espera que NXGN sea rentable en los próximos 3 años.
Ingresos vs. Mercado: Se prevé que los ingresos (6.7% al año) de NXGN crezcan más despacio que el mercado de US (7.9% al año).
Ingresos de alto crecimiento: Se prevé que los ingresos 6.7% al año) de NXGN crezcan más despacio que 20% al año.
Previsiones de crecimiento de los beneficios por acción
Rentabilidad financiera futura
ROE futura: Datos insuficientes para determinar si la rentabilidad financiera de NXGN se prevé que sea elevada dentro de 3 años.